Profound Medical
PROF
55 hedge funds and large institutions have $106M invested in Profound Medical in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 5 closing their positions.
0.83% less ownership
Funds ownership: 45.02% → 44.18% (-0.83%)
1% less capital inflows, than outflows
Capital inflows: $2.78M | Capital outflows: $2.81M
4% less funds holding
Funds holding: 57 → 55 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
48% less call options, than puts
Call options by funds: $330K | Put options by funds: $631K
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$790K |
| 2 |
Royce & Associates
New York
|
+$559K |
| 3 |
LIM
Lagoda Investment Management
New York
|
+$405K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$262K |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$202K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$776K |
| 2 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$496K |
| 3 |
TC
T3 Companies
New York
|
-$359K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$247K |
| 5 |
Jane Street
New York
|
-$238K |
PROF Hedge Fund Activity: Q2 2026 in Review
55 of the 8,358 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q2 2026, worth a combined $106M — up 0.15% from $106M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PROF and 4 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 13 added.
The largest buyer was First Eagle Investment Management, adding an estimated $790K. The largest seller was Velan Capital Investment Management, cutting an estimated $776K.
- 55 institutional investors held Profound Medical (PROF) as of Q2 2026, down from 57 in Q1 2026.
- Funds reported $106M of Profound Medical stock for Q2 2026, up 0.15% quarter-over-quarter.
- 4 funds opened new Profound Medical positions in Q2 2026 and 5 closed out, a net change of -1 holder.
- The largest Profound Medical buyer in Q2 2026 was First Eagle Investment Management, an estimated $790K added.
- The largest Profound Medical seller in Q2 2026 was Velan Capital Investment Management, an estimated $776K sold.
Based on aggregated 13F filings for Q2 2026.